FDA.reportPublic FDA data

Application 202673

Type
ANDA
Sponsor
TARO PHARM INDS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVOCETIRIZINE DIHYDROCHLORIDELEVOCETIRIZINE DIHYDROCHLORIDESOLUTION;ORAL2.5MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51672-4161Levocetirizine DihydrochlorideLevocetirizine dihydrochlorideTaro Pharmaceuticals U.S.A., inc.ANDACurrent
51672-4161Levocetirizine DihydrochlorideLevocetirizine dihydrochlorideTaro Pharmaceuticals U.S.A., inc.ANDACurrent
51672-4161Levocetirizine DihydrochlorideLevocetirizine dihydrochlorideTaro Pharmaceuticals U.S.A., inc.ANDACurrent